Close Menu

SAN FRANCISCO – Roche and Illumina said at the JP Morgan Healthcare Conference here on Monday that they have formed a partnership focused on driving the adoption of next-generation sequencing assays for oncology.

Under the 15-year, non-exclusive agreement with Roche, Illumina will grant Roche rights to develop and distribute in vitro diagnostic tests on Illumina's NextSeq 550Dx System, as well as on its future portfolio of Dx-branded sequencing systems, including the forthcoming NovaSeqDx.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.